Literature DB >> 8503927

Production of monoclonal antibodies to prostromelysin (ProMMP-3) and establishment of a quantitative prostromelysin ELISA assay.

D H Presky1, V L Wilkinson, M D Flannery, E Korkmaz, R Walsky, L J Mondini-Minetti, N Fotouhi, W Levin.   

Abstract

Human prostromelysin (59 kDa) was purified from the conditioned medium of IL-1-stimulated human dermal fibroblasts and anti-prostromelysin monoclonal antibodies were produced and identified by ELISA assay. Using prostromelysin, a C-terminally truncated recombinant form of prostromelysin consisting of amino acids 1-255, and their respective activated enzymes, we have begun mapping the epitopes recognized by these monoclonal antibodies. Various patterns of reactivity against the proenzymes and activated enzymes were observed. In further attempts to map the epitopes, we employed synthetic peptides representing hydrophilic regions of the primary amino acid sequence of prostromelysin. Our monoclonal antibodies did not recognize these peptides, suggesting that the antibodies may be recognizing conformational epitopes composed of non-linear portions of prostromelysin. Using these monoclonal antibodies, we have developed a quantitative prostromelysin sandwich ELISA assay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503927     DOI: 10.1006/bbrc.1993.1632

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Authors:  H Weiler-Guettler; P D Christie; D L Beeler; A M Healy; W W Hancock; H Rayburn; J M Edelberg; R D Rosenberg
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

2.  Stromelysin expression in IL-1 beta stimulated bovine articular cartilage explants.

Authors:  S Wertheimer; S Katz; K Rowan; A Lugo; W Levin; A C Hanglow
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

3.  Cellular localization of thrombomodulin in human epithelium and squamous malignancies.

Authors:  D J Lager; E J Callaghan; S F Worth; T J Raife; S R Lentz
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.